Hyderabad News Desk

Age-Related Macular Degeneration Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – OccuLogix, Pfizer, Genentech

 Breaking News
  • No posts were found

Age-Related Macular Degeneration Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – OccuLogix, Pfizer, Genentech

October 31
22:52 2023
Age-Related Macular Degeneration Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - OccuLogix, Pfizer, Genentech
DelveInsight Business Research LLP
Age-Related Macular Degeneration Pipeline Insights, 2023″ report by DelveInsight outlays comprehensive insights into present clinical development scenario and growth prospects across the Age-Related Macular Degeneration market. A detailed picture of the Age-Related Macular Degeneration pipeline landscape is provided, which includes the disease overview and Age-Related Macular Degeneration treatment guidelines.

Age-Related Macular Degeneration Pipeline Insights, 2023” report by DelveInsight outlays comprehensive insights into present clinical development scenario and growth prospects across the Age-Related Macular Degeneration market. A detailed picture of the Age-Related Macular Degeneration pipeline landscape is provided, which includes the disease overview and Age-Related Macular Degeneration treatment guidelines.

Age-Related Macular Degeneration Epidemiology 

  • Over 200 million individuals worldwide are affected by neovascular age-related macular degeneration (AMD), one of the most widespread causes of blindness.

Key Highlights Age-Related Macular Degeneration Market 

  • Key Companies working in the Age-Related Macular Degeneration market are OccuLogix, Pfizer, Genentech and many others 

  • Key Therapies in Age-Related Macular Degeneration are Rheopheresis, Ranibizumab, Lucentis, and many others 

Age-Related Macular Degeneration Overview

Age-related macular degeneration (AMD) is an eye disease that can blur your central vision. It happens when aging causes damage to the macula — the part of the eye that controls sharp, straight-ahead vision. The macula is part of the retina (the light-sensitive tissue at the back of the eye).

Early dry AMD doesn’t cause any symptoms. In intermediate dry AMD, some people still have no symptoms. Others may notice mild symptoms, like mild blurriness in their central vision or trouble seeing in low lighting. In late AMD (wet or dry type), many people notice that straight lines start to look wavy or crooked. You may also notice a blurry area near the center of your vision. Over time, this blurry area may get bigger or you may see blank spots. Colors may also seem less bright than before, and you may have more trouble seeing in low lighting.

Click here to learn more about the  Age-Related Macular Degeneration Market Landscape

The Report Covers the  Age-Related Macular Degeneration  Epidemiology Segmented by:

  •  Age-Related Macular Degeneration Prevalent cases  

  •  Age-related macular Degeneration Incident cases 

  •  Age-Related Macular Degeneration  Treatment cases 

  •  Age-Related Macular Degeneration Diagnosed cases 

Age-Related Macular Degeneration Market Outlook 

Key Companies Working in the Age Related Macular Degeneration Market

  • OccuLogix

  • Pfizer

  • Genentech 

And many others 

 Age-Related Macular Degeneration Therapies Covered and Analyzed in the Report

  • Rheopheresis

  • Ranibizumab

  • Lucentis

And many others 

 

Learn more about the Key Companies and Emerging Therapies in the  Age-Related Macular Degeneration Market

Table of Contents 

  1. Key Insights 

  2.  Age-Related Macular Degeneration Introduction 

  3.  Executive Summary of Age-Related Macular Degeneration             

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  Age-Related Macular Degeneration Emerging Therapies

  7.  Age-Related Macular Degeneration Market Outlook

  8.  Market Access and Reimbursement of Therapies

  9.  Market Drivers 

  10.  Market Barriers 

  11.  Appendix

  12.  Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

Learn about the detailed offerings of the report @  Age Related Macular Degeneration Market Outlook

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Categories